NZX (NZX) Investor Day 2024 summary

Scientific and operational milestones

• Achieved 60% GLA expression in safflower seeds, surpassing expectations by 10% and improving oil yield economics.

• Received USDA APHIS regulatory clearance for GLA safflower, completing the U.S. regulatory pathway.

• Scaled up prototyping operations from 3 to 300 liters, confirming successful transgenic events in seeds.

• Advanced soybean and pea projects to T2 generation, confirming gene integration and expression.

• Expanded safflower seed multiplication by 42 times and GLASO seeds by 25 times year-over-year.

Business development and strategic partnerships

• Acquired a fully operational soybean processing facility with 10,000 tons/year capacity to enhance downstream capabilities.

• Signed an MOU with Bioceres Crop Solutions for up to 20,000 tons of HB4 soybeans over three years, supporting working capital and sustainability.

• Integrated HB4 soybeans to enable a traceable, sustainable value chain and support ESG goals.

• Combined molecular farming with HB4 platform to advance carbon neutrality and transparent labeling.

Market opportunity and business plan execution

• Total addressable market for 2025 estimated at $827 billion, with a $37 billion serviceable market.

• Business plan includes four stages: traditional soy TVP, sustainable HB4 soy TVP, Moolec Soy 2.0 TVP, and animal proteins in molecular seeds.

• Asset-light approach leverages a global network of farmers, partners, and customers across 14 countries.